Penumbra Q3 2021 Earnings Report
Key Takeaways
Penumbra, Inc. reported financial results for the third quarter ended September 30, 2021, with revenue reaching $190.1 million, a 25.8% increase compared to the third quarter of 2020. The company is increasing its guidance for 2021 total revenue to be in the range of $735 million to $740 million.
Total revenue increased to $190.1 million, a 25.8% increase compared to Q3 2020.
Revenue from vascular products grew by 40.3% to $105.5 million.
Revenue from neuro products grew by 11.5% to $84.7 million.
The company is increasing its guidance for 2021 total revenue to be in the range of $735 million to $740 million, which represents 31% to 32% growth over 2020 revenue.
Penumbra
Penumbra
Penumbra Revenue by Segment
Penumbra Revenue by Geographic Location
Forward Guidance
The Company is increasing its guidance for 2021 total revenue to be in the range of $735 million to $740 million, which represents 31% to 32% growth over 2020 revenue of $560.4 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income